Egln1tm4.1(EGLN1*)Fsl
Targeted Allele Detail
|
Symbol: |
Egln1tm4.1(EGLN1*)Fsl |
Name: |
egl-9 family hypoxia-inducible factor 1; targeted mutation 4.1,Frank Lee |
MGI ID: |
MGI:8186458 |
Synonyms: |
Phd2Tib |
Gene: |
Egln1 Location: Chr8:125635326-125676063 bp, - strand Genetic Position: Chr8, 72.86 cM
|
Alliance: |
Egln1tm4.1(EGLN1*)Fsl page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:289921
|
Parent Cell Line: |
EAP6 (ES Cell)
|
Strain of Origin: |
C57BL/6
|
|
Allele Type: |
|
Targeted (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Egln1tm4.1(EGLN1*)Fsl expresses
1 gene
Knock-in expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
EGLN1 (54583) |
|
|
|
|
|
Mutation details: The targeting vector was designed to replace the endogenous exon 1 of the egl-9 family hypoxia-inducible factor 1 (Egln1) gene with a human exon 1 sequence that harbors a D4E/C127S double amino acid substitution. The targeting construct also consisted of a loxP-flanked neomycin selection cassette. The the floxed neomycin cassette was removed by Cre recombinase.
(J:289921)
|
|
|
|
Original: |
J:289921 Song D, et al., Tibetan PHD2, an allele with loss-of-function properties. Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12230-12238 |
All: |
1 reference(s) |
|